EffeKt Taiwan- Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Taiwan

Prophylaxis Versus On-demand Therapy Through Economic Report

NCT01159587 ·Status: COMPLETED

Extension at 10 Years of the: "Observational Study Evaluating Efficacy and Costs of Secondary Prophylaxis vs On-demand Therapy With Kogenate Bayer in Patients With Severe Haemophilia A."

NCT02581969 ·Status: COMPLETED

Retrospective Study in Chinese Pediatric Hemophilia A Patients With rFⅧ Contained Regular Prophylaxis

NCT02263066 ·Status: COMPLETED

A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A in Taiwan

NCT06684314 ·Status: RECRUITING

BAY14-2222 Prophylaxis and Joint Function Improvement (Adults)

NCT00586521 ·Status: COMPLETED ·Phase: PHASE4

Comparative Pharmacokinetic Study of Two Different Strengths of BAY14-2222

NCT01653639 ·Status: COMPLETED ·Phase: PHASE1

Patient Functioning and Well-being, Economic, and Clinical Impact of Hemophilia A and Its Treatment

NCT02396862 ·Status: COMPLETED

Trial to Evaluate the Efficacy and Safety of a New Full Length Recombinant Human FVIII for Hemophilia A

NCT01029340 ·Status: COMPLETED ·Phase: PHASE3

Prophylaxis Versus on Demand Treatment for Children With Hemophilia A

NCT01810666 ·Status: COMPLETED ·Phase: PHASE4

A Post Approval Commitment Study to Gain More Information on How Safe and Effective KOVALTRY is in Chinese Children, Adolescents /Adults With Severe Hemophilia A

NCT04565236 ·Status: COMPLETED ·Phase: PHASE4

Comparison of Efficacy, Safety and Costs of Recombinant FVIII Products Between On-demand and Secondary Prophylaxis Groups in Haemophilia A Patients

NCT01817868 ·Status: COMPLETED

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

NCT05568719 ·Status: RECRUITING ·Phase: PHASE3

Drug Use Investigation of Kovaltry in Hemophilia A Patients

NCT02941783 ·Status: COMPLETED

Evaluate Efficacy and Safety of Recombinant Factor VIII （rFVIII）Treatment of Severe or Moderately Severe Hemophilia A

NCT02930317 ·Status: UNKNOWN ·Phase: PHASE3

Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult and/or Adolescent Subjects Compared to That of Episodic Treatment

NCT00623480 ·Status: COMPLETED ·Phase: PHASE3

BAY14-2222 Continuous Infusion in Surgeries

NCT00606060 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess Pharmacokinetics and Pharmacodynamics Following Administration of BAY1093884 in Patients With Severe Hemophilia

NCT03481946 ·Status: COMPLETED ·Phase: PHASE1

Trial to Evaluate the Pharmacokinetics and Safety Profile of BAY94-9027 Following Single and Multiple Dose Administration

NCT01184820 ·Status: COMPLETED ·Phase: PHASE1

Assessment of the Risk of Inhibitor Formation in Previously Treated Patients With Severe Hemophilia A

NCT00621673 ·Status: TERMINATED ·Phase: PHASE4

Multiple Escalating Dose Study of BAY1093884 in Adults With Hemophilia A or B With or Without Inhibitors

NCT03597022 ·Status: TERMINATED ·Phase: PHASE2

Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B With Inhibitors

NCT06312475 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Russian Kogenate Pediatric Study

NCT00632814 ·Status: COMPLETED ·Phase: PHASE4

A Study of Adynovate in Previously Treated Chinese Teenagers and Adults With Severe Hemophilia A

NCT05707351 ·Status: COMPLETED ·Phase: PHASE3

Study to Test the Safety of an Investigational Drug Given Repeatedly to Adult Men With Severe Hemophilia

NCT03996486 ·Status: WITHDRAWN ·Phase: PHASE1

A Phase 2/ 3 Trial to Evaluate the Efficacy and Safety of BAY86-6150

NCT01625390 ·Status: COMPLETED ·Phase: PHASE2/PHASE3